Gabriella Miller Kids First Research Act 2.0

Hozzl · 2023-05-11T15:45:15Z

Explore the details of House Bill 623 Gabriella Miller Kids First Research Act 2.0 currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

5/11/2023, 3:45 PM

Summary of Bill HR 623

Bill 117 HR 623, also known as the Gabriella Miller Kids First Research Act 2.0, is a piece of legislation that aims to support pediatric medical research. The bill builds upon the original Gabriella Miller Kids First Research Act, which was passed in 2014.

The main goal of the Gabriella Miller Kids First Research Act 2.0 is to allocate funding for research into childhood diseases and disorders. This funding will come from penalties collected from pharmaceutical companies that have been found to engage in fraudulent practices. The bill specifically targets companies that have been found guilty of defrauding the government in relation to Medicaid or Medicare.

The funds collected from these penalties will be directed towards the National Institutes of Health (NIH) for the purpose of conducting research on pediatric diseases. This research will focus on finding cures and treatments for conditions that affect children, such as cancer, autism, and rare genetic disorders. Overall, the Gabriella Miller Kids First Research Act 2.0 aims to prioritize the health and well-being of children by investing in research that can lead to breakthroughs in pediatric medicine. By using penalties from fraudulent pharmaceutical companies to fund this research, the bill ensures that those who have harmed the healthcare system will contribute to efforts to improve it.

Congressional Summary of HR 623

Gabriella Miller Kids First Research Act 2.0

This bill reauthorizes through FY2027 a pediatric disease research initiative within the National Institutes of Health (NIH) and requires the NIH to coordinate pediatric research activities to avoid duplicative efforts. Additionally, the Department of Health and Human Services must report, within five years, to Congress about research funded through the initiative.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 623

Bill HR 623 is currently in the status of Introduced to Senate since July 28, 2022. Bill HR 623 was introduced during Congress 117 and was introduced to the House on January 28, 2021. Bill HR 623's most recent activity was Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of July 28, 2022

Bipartisan Support of Bill HR 623

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

220

Democrat Cosponsors

144

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 623

Primary Policy Focus

Health

Potential Impact Areas

- Banking and financial institutions regulation

- Cancer

- Child health

- Civil actions and liability

- Department of Health and Human Services

- Drug safety, medical device, and laboratory regulation

- Government trust funds

- Health programs administration and funding

- Medical research

- National Institutes of Health (NIH)

- Research administration and funding

- Securities

- Securities and Exchange Commission (SEC)

Alternate Title(s) of Bill HR 623

Gabriella Miller Kids First Research Act 2.0

To extend the Gabriella Miller Kids First Pediatric Research Program at the National Institutes of Health, and for other purposes.

Gabriella Miller Kids First Research Act 2.0

To require certain civil penalties to be transferred to a fund through which amounts are made available for the Gabriella Miller Kids First Pediatric Research Program at the National Institutes of Health, and for other purposes.

Gabriella Miller Kids First Research Act 2.0